loading...| Preferred Name | Naphazoline | |
| Synonyms |
|
|
| Definitions |
An imidazole derivative and a direct-acting sympathomimetic amine with vasoconstrictive activity. Upon ocular administration, naphazoline exerts its effect by acting on alpha-adrenergic receptors in the arterioles of the conjunctiva to produce vasoconstriction, resulting in decreased conjunctival congestion and diminished itching, irritation and redness. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C61856 |
|
| CAS_Registry |
835-31-4 |
|
| Chemical_Formula |
C14H14N2 |
|
| code |
C61856 |
|
| Contributing_Source |
FDA |
|
| definition |
An imidazole derivative and a direct-acting sympathomimetic amine with vasoconstrictive activity. Upon ocular administration, naphazoline exerts its effect by acting on alpha-adrenergic receptors in the arterioles of the conjunctiva to produce vasoconstriction, resulting in decreased conjunctival congestion and diminished itching, irritation and redness. |
|
| FDA_UNII_Code |
H231GF11BV |
|
| Has_Salt_Form | ||
| in_subset | ||
| label |
Naphazoline |
|
| Legacy Concept Name |
Naphazoline |
|
| Preferred_Name |
Naphazoline |
|
| prefixIRI |
NCIT:C61856 |
|
| prefLabel |
Naphazoline |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0027373 |
|
| subClassOf |